We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App





Heart MRI Scans Can Enable More Accurate COVID-19 Diagnoses and Target Treatments More Effectively

By HospiMedica International staff writers
Posted on 26 Feb 2021
A new study has shown that some patients who have been discharged from hospital following severe COVID-19 illness have evidence of damage to their heart on MRI scans which can help identify different patterns of injury to enable more accurate diagnoses, assess prognosis, and potentially target treatments more effectively.

In the study, researchers at Imperial College Healthcare (London, UK) studied 148 patients who had been hospitalized with severe COVID-19 and who showed raised levels of a protein called troponin in blood tests. More...
Troponin is released into the blood when the heart is injured and can indicate possible damage. The patients studied had been very unwell, with one in three also having been on a ventilator in intensive care. They found that around half of these patients had evidence of damage to the heart on MRI scans performed, on average, around 10 weeks after discharge. Damage included inflammation of the heart muscle, scarring or death of heart tissue, restricted blood supply to the heart and combinations of all three.

Some patients who are hospitalized with COVID-19 have raised troponin levels during the most critical phase of their illness, which is when the body mounts an exaggerated immune response to the infection. Raised levels can occur when an artery becomes blocked or there is inflammation of the heart, but it can be challenging for clinicians to identify the extent or cause of the damage without imaging. The results also show that, despite being very unwell and having raised troponin levels, around half of the patients studied had no evidence on their scan of damage to their heart.

COVID-19 patients who had abnormal troponin levels had MRI scans of the heart after discharge as part of their normal care and these were compared with those from a control group of patients who had not had COVID-19, as well as with 40 healthy volunteers. The study found that around half of patients had evidence of injury, but also that different patterns occurred, suggesting that the heart may be at risk of different types of injury. The researchers also noted that in some cases MRI scans may be showing evidence of existing damage due to the patients’ underlying conditions. The researchers hope that the findings will provide insight into new ways of preventing injury to the heart in the first place, such as early treatment for blood clots, but also for identifying patients who would benefit from treatments to protect their heart function in the future.

“Raised troponin levels are associated with worse outcomes in COVID-19 patients and it is important to understand more about the extent and potential causes of heart damage,” said Dr. Graham Cole, consultant cardiologist at Imperial College Healthcare, who led the study. “MRI scans help identify different patterns of injury, which may enable us to make more accurate diagnoses, assess prognosis, and potentially target treatments more effectively.”

Related Links:
Imperial College Healthcare


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.